title: Salinomycin: a new cancer drug candidate.
abstract: Very recently, it has been shown that it is possible to selectively kill breast cancer stem cells using the ionophore antibiotic, salinomycin. Its ability to kill cancer stem cells and apoptosis-resistant cancer cells may define salinomycin as a novel anticancer drug.
authors.affiliation: Department of Biochemistry, A. Mickiewicz University, Poznan, Poland. adam.huczynski@amu.edu.pl
authors.forename: Adam
authors.initials: A
authors.lastname: Huczynski
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D045744:Cell Line, Tumor; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000378:metabolism; D004249:DNA Damage; D006801:Humans; D009369:Neoplasms; D014411:Neoplastic Stem Cells / Q000187:drug effects; D011714:Pyrans / Q000494:pharmacology*; D000095662:Polyether Polyketides
chemical_list: D000970:Antineoplastic Agents; D050759:Cyclin-Dependent Kinase Inhibitor p21; D011714:Pyrans; C010327:salinomycin; D000095662:Polyether Polyketides